PMC:7341464 / 119-8570
Annnotations
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 81-89 | SP_7 | denotes | COVID-19 |
| T4 | 115-122 | CL:0000763 | denotes | myeloid |
| T5 | 168-176 | SP_7 | denotes | COVID-19 |
| T6 | 557-565 | SP_7 | denotes | COVID-19 |
| T7 | 604-609 | UBERON:0007023 | denotes | adult |
| T8 | 633-638 | UBERON:0007023 | denotes | adult |
| T9 | 661-670 | SP_7 | denotes | SARS-CoV2 |
| T10 | 691-699 | SP_7 | denotes | COVID-19 |
| T11 | 922-927 | UBERON:0007023 | denotes | adult |
| T12 | 1495-1503 | SP_7 | denotes | COVID-19 |
| T13 | 1626-1634 | SP_7 | denotes | COVID-19 |
| T14 | 1730-1736 | GO:0007631 | denotes | intake |
| T15 | 2381-2392 | NCBITaxon:11118 | denotes | coronavirus |
| T16 | 2629-2634 | UBERON:0002398 | denotes | hands |
| T17 | 2655-2660 | UBERON:0002398 | denotes | hands |
| T18 | 2717-2725 | SP_7 | denotes | COVID-19 |
| T19 | 2792-2800 | SP_7 | denotes | COVID-19 |
| T20 | 2875-2883 | SP_7 | denotes | COVID-19 |
| T21 | 2961-2969 | SP_7 | denotes | COVID-19 |
| T22 | 3081-3092 | NCBITaxon:11118 | denotes | coronavirus |
| T24 | 3690-3699 | SP_7 | denotes | SARS-CoV2 |
| T25 | 3890-3898 | CHEBI:45783;CHEBI:45783 | denotes | imatinib |
| T26 | 4099-4107 | SP_7 | denotes | COVID-19 |
| T27 | 4344-4348 | UBERON:0001456 | denotes | face |
| T28 | 4745-4754 | SP_7 | denotes | SARS-CoV2 |
| T29 | 4796-4802 | UBERON:0000473 | denotes | Tested |
| T30 | 4974-4979 | UBERON:0007023 | denotes | adult |
| T31 | 5281-5289 | SP_7 | denotes | COVID-19 |
| T34 | 5826-5835 | SP_7 | denotes | SARS-CoV2 |
| T35 | 6239-6247 | SP_7 | denotes | COVID-19 |
| T36 | 6519-6530 | NCBITaxon:11118 | denotes | coronavirus |
| T37 | 6667-6676 | SP_7 | denotes | SARS-CoV2 |
| T38 | 6677-6682 | NCBITaxon:10239 | denotes | viral |
| T39 | 7162-7170 | SP_7 | denotes | COVID-19 |
| T40 | 7836-7845 | SP_7 | denotes | SARS-CoV2 |
| T41 | 8052-8061 | SP_7 | denotes | SARS-CoV2 |
| T42 | 8114-8122 | SP_7 | denotes | COVID-19 |
| T43 | 8171-8177 | UBERON:0001005 | denotes | airway |
| T44 | 8300-8308 | SP_7 | denotes | COVID-19 |
| T19915 | 81-89 | SP_7 | denotes | COVID-19 |
| T97968 | 115-122 | CL:0000763 | denotes | myeloid |
| T48759 | 168-176 | SP_7 | denotes | COVID-19 |
| T18992 | 557-565 | SP_7 | denotes | COVID-19 |
| T93728 | 604-609 | UBERON:0007023 | denotes | adult |
| T73818 | 633-638 | UBERON:0007023 | denotes | adult |
| T25523 | 661-670 | SP_7 | denotes | SARS-CoV2 |
| T44331 | 691-699 | SP_7 | denotes | COVID-19 |
| T59025 | 922-927 | UBERON:0007023 | denotes | adult |
| T12693 | 1495-1503 | SP_7 | denotes | COVID-19 |
| T93541 | 1626-1634 | SP_7 | denotes | COVID-19 |
| T90775 | 1730-1736 | GO:0007631 | denotes | intake |
| T91107 | 2381-2392 | NCBITaxon:11118 | denotes | coronavirus |
| T37926 | 2629-2634 | UBERON:0002398 | denotes | hands |
| T65523 | 2655-2660 | UBERON:0002398 | denotes | hands |
| T26976 | 2717-2725 | SP_7 | denotes | COVID-19 |
| T91672 | 2792-2800 | SP_7 | denotes | COVID-19 |
| T48204 | 2875-2883 | SP_7 | denotes | COVID-19 |
| T41126 | 2961-2969 | SP_7 | denotes | COVID-19 |
| T6820 | 3081-3092 | NCBITaxon:11118 | denotes | coronavirus |
| T70513 | 3690-3699 | SP_7 | denotes | SARS-CoV2 |
| T92402 | 3890-3898 | CHEBI:45783;CHEBI:45783 | denotes | imatinib |
| T20974 | 4099-4107 | SP_7 | denotes | COVID-19 |
| T88967 | 4344-4348 | UBERON:0001456 | denotes | face |
| T28626 | 4745-4754 | SP_7 | denotes | SARS-CoV2 |
| T93531 | 4796-4802 | UBERON:0000473 | denotes | Tested |
| T59311 | 4974-4979 | UBERON:0007023 | denotes | adult |
| T51667 | 5281-5289 | SP_7 | denotes | COVID-19 |
| T32 | 6239-6247 | SP_7 | denotes | COVID-19 |
| T80344 | 6239-6247 | SP_7 | denotes | COVID-19 |
| T88389 | 6519-6530 | NCBITaxon:11118 | denotes | coronavirus |
| T32342 | 6667-6676 | SP_7 | denotes | SARS-CoV2 |
| T73672 | 6677-6682 | NCBITaxon:10239 | denotes | viral |
| T84389 | 7162-7170 | SP_7 | denotes | COVID-19 |
| T22107 | 7836-7845 | SP_7 | denotes | SARS-CoV2 |
| T77654 | 8052-8061 | SP_7 | denotes | SARS-CoV2 |
| T85367 | 8114-8122 | SP_7 | denotes | COVID-19 |
| T27737 | 8171-8177 | UBERON:0001005 | denotes | airway |
| T76221 | 8300-8308 | SP_7 | denotes | COVID-19 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 4344-4348 | Body_part | denotes | face | http://purl.org/sig/ont/fma/fma24728 |
| T2 | 4637-4643 | Body_part | denotes | throat | http://purl.org/sig/ont/fma/fma228738 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 2629-2634 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T2 | 2655-2660 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T3 | 4279-4284 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T4 | 4308-4313 | Body_part | denotes | hands | http://purl.obolibrary.org/obo/UBERON_0002398 |
| T5 | 4344-4348 | Body_part | denotes | face | http://purl.obolibrary.org/obo/UBERON_0001456 |
| T6 | 4637-4643 | Body_part | denotes | throat | http://purl.obolibrary.org/obo/UBERON_0000341 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T5 | 81-89 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 134-137 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T8 | 168-176 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T9 | 191-194 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T11 | 557-565 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T12 | 610-613 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T14 | 661-665 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T15 | 691-699 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T16 | 859-862 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T18 | 1119-1122 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T20 | 1495-1503 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T21 | 1574-1577 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T23 | 1618-1621 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T25 | 1626-1634 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T26 | 1876-1879 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T28 | 2188-2191 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T30 | 2281-2290 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T31 | 2332-2335 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T33 | 2717-2725 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T34 | 2792-2800 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T35 | 2812-2815 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T37 | 2875-2883 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T38 | 2895-2898 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T40 | 2961-2969 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T41 | 3004-3007 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T43 | 3273-3281 | Disease | denotes | rhinitis | http://purl.obolibrary.org/obo/MONDO_0003014 |
| T44 | 3469-3477 | Disease | denotes | rhinitis | http://purl.obolibrary.org/obo/MONDO_0003014 |
| T45 | 3690-3694 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T46 | 3917-3920 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T48 | 4099-4107 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T49 | 4111-4114 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T51 | 4573-4581 | Disease | denotes | Rhinitis | http://purl.obolibrary.org/obo/MONDO_0003014 |
| T52 | 4632-4643 | Disease | denotes | Sore throat | http://purl.obolibrary.org/obo/MONDO_0002258 |
| T53 | 4745-4749 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T54 | 5048-5057 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
| T55 | 5281-5289 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T56 | 5826-5830 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T57 | 6239-6247 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T58 | 6251-6254 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T60 | 6392-6395 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T62 | 6667-6671 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T63 | 6677-6696 | Disease | denotes | viral infections in | http://purl.obolibrary.org/obo/MONDO_0005108 |
| T64 | 6697-6700 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T66 | 7162-7170 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T67 | 7171-7180 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T68 | 7195-7198 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T70 | 7782-7789 | Disease | denotes | anxiety | http://purl.obolibrary.org/obo/MONDO_0005618|http://purl.obolibrary.org/obo/MONDO_0011918 |
| T72 | 7836-7840 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T73 | 7980-7983 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T75 | 8052-8056 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T76 | 8062-8071 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T77 | 8075-8078 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T79 | 8114-8122 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T80 | 8251-8254 | Disease | denotes | CML | http://purl.obolibrary.org/obo/MONDO_0001014|http://purl.obolibrary.org/obo/MONDO_0011996 |
| T82 | 8300-8308 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T83 | 8309-8318 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 52-54 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
| T3 | 52-54 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
| T4 | 388-389 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T5 | 462-463 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T6 | 808-813 | http://purl.obolibrary.org/obo/CLO_0001236 | denotes | 2], a |
| T7 | 842-849 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focused |
| T8 | 997-998 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T9 | 1090-1093 | http://purl.obolibrary.org/obo/CLO_0001562 | denotes | a 2 |
| T10 | 1090-1093 | http://purl.obolibrary.org/obo/CLO_0001563 | denotes | a 2 |
| T11 | 1166-1167 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T12 | 1312-1319 | http://www.ebi.ac.uk/efo/EFO_0000881 | denotes | digital |
| T13 | 1650-1651 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T14 | 1714-1722 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focusing |
| T15 | 1759-1766 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T16 | 1872-1875 | http://purl.obolibrary.org/obo/CLO_0001079 | denotes | 148 |
| T17 | 1933-1935 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T18 | 1937-1942 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | males |
| T19 | 1937-1942 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | males |
| T20 | 2208-2209 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T21 | 2379-2380 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T22 | 2831-2834 | http://purl.obolibrary.org/obo/CLO_0001079 | denotes | 148 |
| T23 | 2911-2913 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
| T24 | 3116-3117 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T25 | 3143-3144 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T26 | 3155-3157 | http://purl.obolibrary.org/obo/CLO_0053799 | denotes | 45 |
| T27 | 3679-3685 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T28 | 3732-3738 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T29 | 3841-3842 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T30 | 3851-3855 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
| T31 | 3851-3855 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
| T32 | 3966-3972 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T33 | 4152-4155 | http://purl.obolibrary.org/obo/CLO_0001079 | denotes | 148 |
| T34 | 4261-4262 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T35 | 4298-4299 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T36 | 4333-4334 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T37 | 4344-4348 | http://purl.obolibrary.org/obo/UBERON_0001456 | denotes | face |
| T38 | 4364-4365 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T39 | 4432-4433 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T40 | 4506-4507 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T41 | 4537-4538 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T42 | 4553-4555 | http://purl.obolibrary.org/obo/CLO_0050507 | denotes | 22 |
| T43 | 4559-4560 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T44 | 4597-4599 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
| T45 | 4755-4762 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T46 | 4765-4771 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Tested |
| T47 | 4796-4802 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | Tested |
| T48 | 4831-4837 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T49 | 5753-5754 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T50 | 5815-5821 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T51 | 5866-5872 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T52 | 6304-6310 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T53 | 6324-6327 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T54 | 6726-6728 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
| T55 | 6726-6728 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
| T56 | 6748-6749 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T57 | 6871-6877 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T58 | 6904-6906 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
| T59 | 6904-6906 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
| T60 | 6942-6943 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T61 | 7051-7058 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T62 | 7140-7148 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focusing |
| T63 | 7386-7393 | http://www.ebi.ac.uk/efo/EFO_0000881 | denotes | digital |
| T64 | 7425-7426 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T65 | 7501-7502 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T66 | 7653-7654 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T67 | 7702-7709 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focused |
| T68 | 7846-7852 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T69 | 7929-7931 | http://purl.obolibrary.org/obo/CLO_0001022 | denotes | Li |
| T70 | 7929-7931 | http://purl.obolibrary.org/obo/CLO_0007314 | denotes | Li |
| T71 | 8042-8043 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T72 | 8171-8177 | http://purl.obolibrary.org/obo/UBERON_0001005 | denotes | airway |
| T73 | 8215-8220 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focus |
| T74 | 8236-8243 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
| T75 | 8269-8280 | http://purl.obolibrary.org/obo/BFO_0000030 | denotes | objectively |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 52-54 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
| T2 | 405-410 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T3 | 980-985 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T4 | 3851-3855 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
| T5 | 3890-3898 | Chemical | denotes | imatinib | http://purl.obolibrary.org/obo/CHEBI_45783 |
| T6 | 5147-5153 | Chemical | denotes | corona | http://purl.obolibrary.org/obo/CHEBI_37409 |
| T7 | 6726-6728 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
| T8 | 6904-6906 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
| T9 | 7663-7668 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T10 | 7806-7811 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T11 | 7929-7931 | Chemical | denotes | Li | http://purl.obolibrary.org/obo/CHEBI_30145 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 6677-6693 | http://purl.obolibrary.org/obo/GO_0016032 | denotes | viral infections |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 0-14 | Sentence | denotes | To the Editor: |
| T4 | 15-143 | Sentence | denotes | We read with interest the article by Li et al. first to report on COVID-19 in patients with chronic myeloid leukaemia (CML) [1]. |
| T5 | 144-306 | Sentence | denotes | They found an increased COVID-19 prevalence in CML patients of the Hubei region in China when compared to the prevalence of the general population of that region. |
| T6 | 307-428 | Sentence | denotes | Unfortunately, in this retrospective study, follow-up data were not provided and a direct control group was not included. |
| T7 | 429-757 | Sentence | denotes | We report preliminary results of a prospective Dutch observational cohort study that assessed differences in susceptibility for COVID-19 and severity of the disease course in adult CML patients and their adult housemates during the SARS-CoV2 pandemic (the first COVID-19 case was identified on February 27th in the Netherlands). |
| T8 | 758-901 | Sentence | denotes | Patients were invited to participate via CMyLife [2], a nationwide web-based portal focused on Dutch CML patients, from April 6th 2020 onwards. |
| T9 | 902-1047 | Sentence | denotes | If available, their adult housemates (e.g., spouses) were included as control group, providing a better representation of the general population. |
| T10 | 1048-1118 | Sentence | denotes | Surveys were performed at baseline and at a 2-weekly follow-up period. |
| T11 | 1119-1235 | Sentence | denotes | CML patients receiving TKI treatment or having a discontinuation of their TKI treatment were invited to participate. |
| T12 | 1236-1382 | Sentence | denotes | The study was approved by the Radboudumc institutional ethics committee and digital informed consent was obtained from both patients and partners. |
| T13 | 1383-1635 | Sentence | denotes | At inclusion, information was gathered on demographics, self-reported comorbidity, vaccinations, health rating, COVID-19 related symptoms and hospital admissions and additional for patients; CML course, patients’ perceptions regarding CML and COVID-19. |
| T14 | 1636-1801 | Sentence | denotes | Every 2 weeks a truncated shorter version of the questionnaire was conducted, focusing on TKI intake, preventive measures, testing, symptoms and hospital admissions. |
| T15 | 1802-2048 | Sentence | denotes | At time of submission, 167 patients have registered for the study and 148 CML patients (median age, 57.5 years; range 26–82 years; 48% males) and 123 housemates (median age 60 years, range 24–88 years) were included, with enrolment still ongoing. |
| T16 | 2049-2117 | Sentence | denotes | The baseline characteristics are presented in Supplementary Table 1. |
| T17 | 2118-2161 | Sentence | denotes | The majority (88.4%) had taken TKI therapy. |
| T18 | 2162-2269 | Sentence | denotes | Approximately half of the CML patients versus a third of controls had comorbidity that required medication. |
| T19 | 2270-2375 | Sentence | denotes | The annual influenza vaccination was received by 58.0% of the CML patients and 35.8% of their housemates. |
| T20 | 2376-2530 | Sentence | denotes | If a coronavirus vaccine would become available, both patients and their housemates would be largely willing to take this (76.3% and 68.9%, respectively). |
| T21 | 2531-2684 | Sentence | denotes | The majority applied preventive measures as recommended by national institutes (e.g., not shaking hands, frequently washing hands and social distancing). |
| T22 | 2685-2747 | Sentence | denotes | Patients’ perceptions regarding COVID-19 are shown in Table 1. |
| T23 | 2748-2816 | Sentence | denotes | Table 1 Reported perceptions of patients on COVID-19 related to CML. |
| T24 | 2817-2835 | Sentence | denotes | Patients (N = 148) |
| T25 | 2836-2841 | Sentence | denotes | % (n) |
| T26 | 2842-2898 | Sentence | denotes | Thinks to be more susceptible to COVID-19 because of CML |
| T27 | 2899-2914 | Sentence | denotes | Yes 32.4 (48) |
| T28 | 2915-2929 | Sentence | denotes | No 35.8 (53) |
| T29 | 2930-2953 | Sentence | denotes | Do not know 31.8 (47) |
| T30 | 2954-3007 | Sentence | denotes | Thinks COVID-19 course will be more severe due to CML |
| T31 | 3008-3023 | Sentence | denotes | Yes 35.8 (53) |
| T32 | 3024-3038 | Sentence | denotes | No 20.3 (30) |
| T33 | 3039-3062 | Sentence | denotes | Do not know 43.9 (65) |
| T34 | 3063-3092 | Sentence | denotes | Worries about the coronavirus |
| T35 | 3093-3113 | Sentence | denotes | Not at all 5.4 (8) |
| T36 | 3114-3134 | Sentence | denotes | A little 54.7 (81) |
| T37 | 3135-3158 | Sentence | denotes | Quite a bit 30.4 (45) |
| T38 | 3159-3179 | Sentence | denotes | Very much 9.5 (14) |
| T39 | 3180-3256 | Sentence | denotes | Next we analysed symptoms of patients and housemates at inclusion (Table 2). |
| T40 | 3257-3371 | Sentence | denotes | Among patients, rhinitis was the most reported symptom (16.9%), followed by coughing (14.2%) and dyspnoea (10.8%). |
| T41 | 3372-3395 | Sentence | denotes | Fever was not reported. |
| T42 | 3396-3446 | Sentence | denotes | Many (69.6%) patients reported to be symptom free. |
| T43 | 3447-3566 | Sentence | denotes | Among the housemates, rhinitis was reported in 8.9% of cases, and coughing and dyspnoea in 6.5% and 2.4%, respectively. |
| T44 | 3567-3597 | Sentence | denotes | Again, fever was not reported. |
| T45 | 3598-3651 | Sentence | denotes | The majority (84.6%) reported to be free of symptoms. |
| T46 | 3652-3823 | Sentence | denotes | Only two patients had been tested for SARS-CoV2 at study inclusion, of whom one tested positive and reported to have been admitted to the hospital (without ICU admission). |
| T47 | 3824-3946 | Sentence | denotes | This patient was a 62 year male without comorbidity, who received imatinib therapy since the CML diagnosis 2 years before. |
| T48 | 3947-4010 | Sentence | denotes | No housemates were tested nor reported any hospital admissions. |
| T49 | 4011-4137 | Sentence | denotes | Table 2 Information on preventive measures, symptoms and hospital admissions related to COVID-19 in CML patients at inclusion. |
| T50 | 4138-4177 | Sentence | denotes | Patients (N = 148) Housemates (N = 124) |
| T51 | 4178-4189 | Sentence | denotes | % (n) % (n) |
| T52 | 4190-4228 | Sentence | denotes | Visited affected areaa 3.4 (5) 4.1 (5) |
| T53 | 4229-4249 | Sentence | denotes | Preventive measuresb |
| T54 | 4250-4262 | Sentence | denotes | None 0 N/A |
| T55 | 4263-4299 | Sentence | denotes | Avoid shaking hands 85.1 (126) N/A |
| T56 | 4300-4334 | Sentence | denotes | Clean hands often 84.5 (125) N/A |
| T57 | 4335-4365 | Sentence | denotes | Use of face mask 2.7 (4) N/A |
| T58 | 4366-4433 | Sentence | denotes | Working from home, just as same-function colleagues 31.8 (47) N/A |
| T59 | 4434-4507 | Sentence | denotes | Working from home, in contrary to same-function colleagues 6.8 (10) N/A |
| T60 | 4508-4538 | Sentence | denotes | Self-isolation 41.2 (61) N/A |
| T61 | 4539-4560 | Sentence | denotes | Other 14.9 (22) N/A |
| T62 | 4561-4570 | Sentence | denotes | Symptomsb |
| T63 | 4571-4600 | Sentence | denotes | Rhinitis 16.9 (25) 8.9 (11) |
| T64 | 4601-4629 | Sentence | denotes | Coughing 14.2 (21) 6.5 (8) |
| T65 | 4630-4659 | Sentence | denotes | Sore throat 4.1 (6) 2.4 (3) |
| T66 | 4660-4688 | Sentence | denotes | Dyspnoea 10.8 (16) 2.4 (3) |
| T67 | 4689-4708 | Sentence | denotes | Fever 0 (0) 0 (0) |
| T68 | 4709-4744 | Sentence | denotes | No symptoms 69.6 (103) 84.6 (104) |
| T69 | 4745-4762 | Sentence | denotes | SARS-CoV2 testing |
| T70 | 4763-4793 | Sentence | denotes | Tested, positive 0.7 (1) 0.0 |
| T71 | 4794-4824 | Sentence | denotes | Tested, negative 0.7 (1) 0.0 |
| T72 | 4825-4858 | Sentence | denotes | Not tested 98.0 (145) 100 (123) |
| T73 | 4859-4878 | Sentence | denotes | Unknown 0.7 (1) 0 |
| T74 | 4879-4914 | Sentence | denotes | Hospital admissionc 0.7 (1) 0.0 (0) |
| T75 | 4915-4962 | Sentence | denotes | Intensive Care Unit admission 0.0 (0) 0.0 (0) |
| T76 | 4963-5002 | Sentence | denotes | Lives with adult housemate 85.9 (128) – |
| T77 | 5003-5018 | Sentence | denotes | N = 131 N = 106 |
| T78 | 5019-5030 | Sentence | denotes | % (n) % (n) |
| T79 | 5031-5039 | Sentence | denotes | Vaccines |
| T80 | 5040-5069 | Sentence | denotes | Annual influenza vaccination |
| T81 | 5070-5095 | Sentence | denotes | Yes 58.0 (76) 35.8 (38) |
| T82 | 5096-5120 | Sentence | denotes | No 42.0 (55) 64.1 (68) |
| T83 | 5121-5161 | Sentence | denotes | If available, would take corona vaccine |
| T84 | 5162-5189 | Sentence | denotes | Yes 76.3 (100) 68.9 (73) |
| T85 | 5190-5211 | Sentence | denotes | No 3.8 (5) 0.9 (1) |
| T86 | 5212-5246 | Sentence | denotes | Do not know 19.8 (26) 30.2 (32) |
| T87 | 5247-5365 | Sentence | denotes | aAffected areas with high risk of COVID-19 as established by National Institute for Public Health and the Environment: |
| T88 | 5366-5454 | Sentence | denotes | Italy, Austria, Nordrhein Westfalen (Germany), Madrid (Spain), China, South Korea, Iran. |
| T89 | 5455-5482 | Sentence | denotes | bMultiple answers possible. |
| T90 | 5483-5574 | Sentence | denotes | cHospital/ICU admission because of the following symptoms: coughing, dyspnoea and/or fever. |
| T91 | 5575-5696 | Sentence | denotes | Currently, most subjects have completed their first and second 2-weekly follow-up questionnaires (Supplementary Table 2). |
| T92 | 5697-5752 | Sentence | denotes | No patients reported (temporarily) TKI discontinuation. |
| T93 | 5753-5882 | Sentence | denotes | A further six persons (two patients and four housemates) were tested for SARS-CoV2 during this follow-up and all tested negative. |
| T94 | 5883-5920 | Sentence | denotes | No hospital admissions were reported. |
| T95 | 5921-6078 | Sentence | denotes | At 2 weeks, 74.2% (n = 95) of the patients reported to be free of symptoms, compared to 79.4% (n = 100) and 88.9% (n = 16) at four and 6 weeks, respectively. |
| T96 | 6079-6175 | Sentence | denotes | For housemates these rates were 87.6% (n = 106), 91.6% (n = 98) and 100% (n = 15), respectively. |
| T97 | 6176-6264 | Sentence | denotes | To conclude, we found no significantly increased prevalence of COVID-19 in CML patients. |
| T98 | 6265-6358 | Sentence | denotes | Only one patient (0.7%) reported to be tested positive and has been admitted to the hospital. |
| T99 | 6359-6531 | Sentence | denotes | These findings are important for CML patients and professionals (prescribers of TKI) as almost 40% of patients reported to be substantially concerned about the coronavirus. |
| T100 | 6532-6735 | Sentence | denotes | The prevalence rate is in line with the reported 0.3% in the general Dutch population [3], and with the reported low prevalence of <1% SARS-CoV2 viral infections in CML patients in the study of Li et al. |
| T101 | 6736-6892 | Sentence | denotes | We included a representative control cohort of housemates of similar age and geographical spreading as the patients, of whom none were tested positive (0%). |
| T102 | 6893-7125 | Sentence | denotes | Similar to Li et al. (0.9% vs 0.1%), we did find a slightly higher percentage of infected patients than in the general population (0.7% vs 0.3%) based on PCR testing on clinical indication, but this is not statistically significant. |
| T103 | 7126-7222 | Sentence | denotes | Other studies focusing primarily on COVID-19 infection prevalence in CML population are lacking. |
| T104 | 7223-7272 | Sentence | denotes | There are strengths and limitations to our study. |
| T105 | 7273-7594 | Sentence | denotes | Although there may have been some self-selection bias in our study, the recruitment through the national CMyLife digital patient platform did allow for a substantial and geographically nationwide spread of participants, also in a time when many patients isolated themselves and hospital visits were limited when possible. |
| T106 | 7595-7669 | Sentence | denotes | Also, our study was performed prospectively, and included a control group. |
| T107 | 7670-7812 | Sentence | denotes | Furthermore, our questionnaires focused on patients’ perceptions, offering insights in the substantial level of anxiety in this patient group. |
| T108 | 7813-7898 | Sentence | denotes | However, the number of SARS-CoV2 tested subjects was low, limiting statistical power. |
| T109 | 7899-8132 | Sentence | denotes | Taken together, the report by Li et al. and our current data may offer relief to CML patients in general that the absolute risk of contracting a serious SARS-CoV2 infection in CML patients, was low (<1%) during the COVID-19 pandemic. |
| T110 | 8133-8330 | Sentence | denotes | However, as we did observe more upper airway symptoms and further research should focus on serological testing in the CML population to objectively assess subclinical COVID-19 infection prevalence. |
| T111 | 8331-8403 | Sentence | denotes | Finally, our study supports that patients can safely continue their TKI. |
| T112 | 8405-8430 | Sentence | denotes | Supplementary information |
| T113 | 8432-8451 | Sentence | denotes | Supplemental Tables |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 115-132 | Phenotype | denotes | myeloid leukaemia | http://purl.obolibrary.org/obo/HP_0012324 |
| T2 | 3273-3281 | Phenotype | denotes | rhinitis | http://purl.obolibrary.org/obo/HP_0012384 |
| T3 | 3333-3341 | Phenotype | denotes | coughing | http://purl.obolibrary.org/obo/HP_0012735 |
| T4 | 3354-3362 | Phenotype | denotes | dyspnoea | http://purl.obolibrary.org/obo/HP_0002094 |
| T5 | 3372-3377 | Phenotype | denotes | Fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T6 | 3469-3477 | Phenotype | denotes | rhinitis | http://purl.obolibrary.org/obo/HP_0012384 |
| T7 | 3513-3521 | Phenotype | denotes | coughing | http://purl.obolibrary.org/obo/HP_0012735 |
| T8 | 3526-3534 | Phenotype | denotes | dyspnoea | http://purl.obolibrary.org/obo/HP_0002094 |
| T9 | 3574-3579 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T10 | 4573-4581 | Phenotype | denotes | Rhinitis | http://purl.obolibrary.org/obo/HP_0012384 |
| T11 | 4603-4611 | Phenotype | denotes | Coughing | http://purl.obolibrary.org/obo/HP_0012735 |
| T12 | 4632-4643 | Phenotype | denotes | Sore throat | http://purl.obolibrary.org/obo/HP_0033050 |
| T13 | 4662-4670 | Phenotype | denotes | Dyspnoea | http://purl.obolibrary.org/obo/HP_0002094 |
| T14 | 4691-4696 | Phenotype | denotes | Fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T15 | 5542-5550 | Phenotype | denotes | coughing | http://purl.obolibrary.org/obo/HP_0012735 |
| T16 | 5552-5560 | Phenotype | denotes | dyspnoea | http://purl.obolibrary.org/obo/HP_0002094 |
| T17 | 5568-5573 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
| T18 | 7782-7789 | Phenotype | denotes | anxiety | http://purl.obolibrary.org/obo/HP_0000739 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 15 | 93-101 | Species | denotes | patients | Tax:9606 |
| 16 | 195-203 | Species | denotes | patients | Tax:9606 |
| 17 | 81-89 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 18 | 107-132 | Disease | denotes | chronic myeloid leukaemia | MESH:C580075 |
| 19 | 134-137 | Disease | denotes | CML | MESH:D015464 |
| 20 | 168-176 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 21 | 191-194 | Disease | denotes | CML | MESH:D015464 |
| 30 | 614-622 | Species | denotes | patients | Tax:9606 |
| 31 | 661-670 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 32 | 758-766 | Species | denotes | Patients | Tax:9606 |
| 33 | 863-871 | Species | denotes | patients | Tax:9606 |
| 34 | 557-565 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 35 | 610-613 | Disease | denotes | CML | MESH:D015464 |
| 36 | 691-699 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 37 | 859-862 | Disease | denotes | CML | MESH:D015464 |
| 41 | 1123-1131 | Species | denotes | patients | Tax:9606 |
| 42 | 1360-1368 | Species | denotes | patients | Tax:9606 |
| 43 | 1119-1122 | Disease | denotes | CML | MESH:D015464 |
| 50 | 1564-1572 | Species | denotes | patients | Tax:9606 |
| 51 | 1586-1594 | Species | denotes | patients | Tax:9606 |
| 52 | 1495-1503 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 53 | 1574-1577 | Disease | denotes | CML | MESH:D015464 |
| 54 | 1618-1621 | Disease | denotes | CML | MESH:D015464 |
| 55 | 1626-1634 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 59 | 1829-1837 | Species | denotes | patients | Tax:9606 |
| 60 | 1880-1888 | Species | denotes | patients | Tax:9606 |
| 61 | 1876-1879 | Disease | denotes | CML | MESH:D015464 |
| 68 | 2817-2825 | Species | denotes | Patients | Tax:9606 |
| 69 | 3081-3092 | Species | denotes | coronavirus | Tax:11118 |
| 70 | 2875-2883 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 71 | 2895-2898 | Disease | denotes | CML | MESH:D015464 |
| 72 | 2961-2969 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 73 | 3004-3007 | Disease | denotes | CML | MESH:D015464 |
| 77 | 2780-2788 | Species | denotes | patients | Tax:9606 |
| 78 | 2792-2800 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 79 | 2812-2815 | Disease | denotes | CML | MESH:D015464 |
| 88 | 2192-2200 | Species | denotes | patients | Tax:9606 |
| 89 | 2336-2344 | Species | denotes | patients | Tax:9606 |
| 90 | 2381-2392 | Species | denotes | coronavirus | Tax:11118 |
| 91 | 2430-2438 | Species | denotes | patients | Tax:9606 |
| 92 | 2685-2693 | Species | denotes | Patients | Tax:9606 |
| 93 | 2188-2191 | Disease | denotes | CML | MESH:D015464 |
| 94 | 2332-2335 | Disease | denotes | CML | MESH:D015464 |
| 95 | 2717-2725 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 99 | 4115-4123 | Species | denotes | patients | Tax:9606 |
| 100 | 4099-4107 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 101 | 4111-4114 | Disease | denotes | CML | MESH:D015464 |
| 103 | 5281-5289 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 107 | 5542-5550 | Disease | denotes | coughing | MESH:D003371 |
| 108 | 5552-5560 | Disease | denotes | dyspnoea | MESH:D004417 |
| 109 | 5568-5573 | Disease | denotes | fever | MESH:D005334 |
| 125 | 3209-3217 | Species | denotes | patients | Tax:9606 |
| 126 | 3263-3271 | Species | denotes | patients | Tax:9606 |
| 127 | 3409-3417 | Species | denotes | patients | Tax:9606 |
| 128 | 3661-3669 | Species | denotes | patients | Tax:9606 |
| 129 | 3690-3699 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 130 | 3829-3836 | Species | denotes | patient | Tax:9606 |
| 131 | 3890-3898 | Chemical | denotes | imatinib | MESH:D000068877 |
| 132 | 3273-3281 | Disease | denotes | rhinitis | MESH:D012220 |
| 133 | 3333-3341 | Disease | denotes | coughing | MESH:D003371 |
| 134 | 3354-3362 | Disease | denotes | dyspnoea | MESH:D004417 |
| 135 | 3372-3377 | Disease | denotes | Fever | MESH:D005334 |
| 136 | 3469-3477 | Disease | denotes | rhinitis | MESH:D012220 |
| 137 | 3513-3534 | Disease | denotes | coughing and dyspnoea | MESH:D003371 |
| 138 | 3574-3579 | Disease | denotes | fever | MESH:D005334 |
| 139 | 3917-3920 | Disease | denotes | CML | MESH:D015464 |
| 145 | 5700-5708 | Species | denotes | patients | Tax:9606 |
| 146 | 5767-5774 | Species | denotes | persons | Tax:9606 |
| 147 | 5780-5788 | Species | denotes | patients | Tax:9606 |
| 148 | 5826-5835 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 149 | 5955-5963 | Species | denotes | patients | Tax:9606 |
| 168 | 6255-6263 | Species | denotes | patients | Tax:9606 |
| 169 | 6274-6281 | Species | denotes | patient | Tax:9606 |
| 170 | 6396-6404 | Species | denotes | patients | Tax:9606 |
| 171 | 6461-6469 | Species | denotes | patients | Tax:9606 |
| 172 | 6519-6530 | Species | denotes | coronavirus | Tax:11118 |
| 173 | 6667-6676 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 174 | 6701-6709 | Species | denotes | patients | Tax:9606 |
| 175 | 6843-6851 | Species | denotes | patients | Tax:9606 |
| 176 | 6983-6991 | Species | denotes | patients | Tax:9606 |
| 177 | 6239-6247 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 178 | 6251-6254 | Disease | denotes | CML | MESH:D015464 |
| 179 | 6392-6395 | Disease | denotes | CML | MESH:D015464 |
| 180 | 6677-6693 | Disease | denotes | viral infections | MESH:D001102 |
| 181 | 6697-6700 | Disease | denotes | CML | MESH:D015464 |
| 182 | 6974-6982 | Disease | denotes | infected | MESH:D007239 |
| 183 | 7162-7170 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 184 | 7171-7180 | Disease | denotes | infection | MESH:D007239 |
| 185 | 7195-7198 | Disease | denotes | CML | MESH:D015464 |
| 193 | 7394-7401 | Species | denotes | patient | Tax:9606 |
| 194 | 7479-7491 | Species | denotes | participants | Tax:9606 |
| 195 | 7518-7526 | Species | denotes | patients | Tax:9606 |
| 196 | 7713-7721 | Species | denotes | patients | Tax:9606 |
| 197 | 7798-7805 | Species | denotes | patient | Tax:9606 |
| 198 | 7836-7845 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 199 | 7782-7789 | Disease | denotes | anxiety | MESH:D001007 |
| 211 | 7984-7992 | Species | denotes | patients | Tax:9606 |
| 212 | 8052-8061 | Species | denotes | SARS-CoV2 | Tax:2697049 |
| 213 | 8079-8087 | Species | denotes | patients | Tax:9606 |
| 214 | 8364-8372 | Species | denotes | patients | Tax:9606 |
| 215 | 7980-7983 | Disease | denotes | CML | MESH:D015464 |
| 216 | 8062-8071 | Disease | denotes | infection | MESH:D007239 |
| 217 | 8075-8078 | Disease | denotes | CML | MESH:D015464 |
| 218 | 8114-8122 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 219 | 8251-8254 | Disease | denotes | CML | MESH:D015464 |
| 220 | 8300-8308 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 221 | 8309-8318 | Disease | denotes | infection | MESH:D007239 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32641732-32412424-66302041 | 808-809 | 32412424 | denotes | 2 |